Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes

Proteomics

Volumn 10, Issue 17, 2010, Pages 3165-3175

  Imperlini, Esther ^a   Mancini, Annamaria ^a   Spaziani, Sara ^b,c   Martone, Domenico ^b,c   Alfieri, Andreina ^b,d   Gemei, Marica ^c   Del Vecchio, Luigi ^c,d   Buono, Pasqualina ^b,d   Orrù, Stefania ^a,b  

^a IRCCS SDN   (Italy)

^b UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

2 D DIGE; Androgen receptor; Cell biology; Dihydrotestosterone; Lymphocytes; Steroids abuse

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; PROTEOME;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DNA SEQUENCE; GENETIC CODE; HORMONE RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ADULT; APOPTOSIS; CASPASE 3; COMPUTATIONAL BIOLOGY; DIHYDROTESTOSTERONE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; PROTEOME; PROTEOMICS; RECEPTORS, ANDROGEN; REPRODUCIBILITY OF RESULTS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 77956125387     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000079     Document Type: Article

References (46)

1. Verrijdt, G., Schoenmakers, E., Alen, P., Haelens, A. et al., Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol. Endocrinol. 1999, 13, 1558-1570.
2. Verrijdt, G., Schoenmakers, E., Haelens, A., Peeters, B. et al., Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J. Biol. Chem. 2000, 275, 12298-12305.
3. Claessens, F., Denayer, S., Van Tilborgh, N., Kerkhofs, S. et al., Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl. Recept. Signal. 2008, 6, e008.
4. Gao, W., Bohl, C. E., Dalton, J. T., Chemistry and structural biology of androgen receptor. Chem. Rev. 2005, 105, 3352-3370.
5. Russell, D. W., Berman, D. M., Bryant, J. T., Cala, K. M. et al., The molecular genetics of steroid 5 alpha-reductases. Recent Prog. Horm. Res. 1994, 49, 275-284.
6. Oettel, M., Testosterone metabolism, dose-response relationships and receptor polymorphisms: selected pharmacological/ toxicological considerations on benefits versus risks of testosterone therapy in men. Aging Male 2003, 6, 230-256.
7. Balk, S. P., Knudsen, K. E., AR, the cell cycle, and prostate cancer. Nucl. Recept. Signal. 2008, 6, e001.
8. Lösel, R., Wehling, M., Nongenomic actions of steroid hormones. Nat. Rev. Mol. Cell. Biol. 2003, 4, 46-56.
9. Liva, S. M., Voskuhl, R. R., Testosterone acts directly on CD4+T lymphocytes to increase IL-10 production. J. Immunol. 2001, 167, 2060-2067.
10. Caterino, M., Ruoppolo, M., Fulcoli, G., Huynth, T. et al., Transcription factor TBX1 overexpression induces down-regulation of proteins involved in retinoic acid metabolism: a comparative proteomic analysis. J. Proteome Res. 2009, 8, 1515-1526.
11. Pathak, S., Singh, R., Verschoyle, R. D., Greaves, P. et al., Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo. Cancer Lett. 2008, 261, 74-83.
12. Fitch, K. D., Androgenic-anabolic steroids and the Olympic Games. Asian J. Androl. 2008, 10, 384-390.
13. Socas, L., Zumbado, M., Perez-Luzardo, O., Ramos, A. et al., Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br. J. SportsMed. 2005, 39, e27.
14. Street, C., Antonio, J., Cudlipp, D., Androgen use by athletes: a reevaluation of the health risks. Can. J. Appl. Physiol. 1996, 21, 421-440.
15. Martorana, G., Concetti, S., Manferrari, F., Creti, S., Anabolic steroid abuse and renal cell carcinoma. J. Urol. 1999, 162, 2089.
16. Parssinen, M., Kujala, U., Vartiainen, E., Sarna, S., Seppala, T., Increased premature mortality of competitive power-lifters suspected to have used anabolic agents. Int. J. Sports Med. 2000, 21, 225-227.
17. Stergiopoulos, K., Brennan, J. J., Mathews, R., Setaro, J. F., Kort, S., Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature. Vasc. Health Risk Manag. 2008, 4, 1475-1480.
18. Sato, S.M., Schulz, K. M., Sisk, C. L., Wood, R. I., Adolescent and androgens, receptors and reward. Horm. Behav. 2008, 53, 647-658.
19. Wilson, J. D., Androgen abuse by athletes. Endocr. Rev. 1988, 9, 181-191.
20. Mukherjee, B., Mayer, D., Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells. Int. J. Oncol. 2008, 33, 623-629.
21. Kemppainen, J. A., Lane, M. V., Sar, M., Wilson, E. M., Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. J. Biol. Chem. 1992, 267, 968-974.
22. Zhou, Z. X., Lane, M. V., Kemppainen, J. A., French, F. S., Wilson, E. M., Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol. Endocrinol. 1995, 9, 208-218.
23. Wolf, D. A., Herzinger, T., Hermeking, H., Blaschke, D., Horz, W., Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. Mol. Endocrinol. 1993, 7, 924-936.
24. Penning, T. M., Jin, Y., Rizner, T. L., Bauman, D. R., Pre-receptor regulation of the androgen receptor. Mol. Cell. Endocrinol. 2008, 281, 1-8.
25. Ikeda, H., Serria, M. S., Kakizaki, I., Hatayama, I. et al., Activation of mouse Pi-class glutathione S-transferase gene by Nrf2 (NF-E2-related factor 2) and androgen. Biochem. J. 2002, 364, 563-570.
26. Rahman, I., Inflammation and the regulation of glutathione level in lung epithelial cells. Antioxid. Redox Signal. 1999, 1, 425-447.
27. Martinon, F., Burns, K., Tschopp, J., The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10, 417-426.
28. Palvimo, J. J., Reinikainen, P., Ikonen, T., Kallio, P. J. et al., Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem. 1996, 271, 24151-24156.
29. Li, H., Ahonen, T. J., Alanen, K., Xie, J. et al., Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade. Cancer Res. 2004, 64, 4774-4782.
30. Tan, S. H., Dagvadorj, A., Shen, F., Gu, L. et al., Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells. Cancer Res. 2008, 68, 236-248.
31. Chatterjee-Kishore, M., Wright, K. L., Ting, J. P., Stark, G. R., How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J. 2000, 19, 4111-4122.
32. Mayeur, G. L., Kung, W. J., Martinez, A., Izumiya, C. et al., Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells. J. Biol. Chem. 2005, 280, 10827-10833.
33. Difilippantonio, M. J., Zhu, J., Chen, H. T., Meffre, E. et al., DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature 2000, 404, 510-514.
34. Kim, G. W., Noshita, N., Sugawara, T., Chan, P. H., Early decrease in DNA repair proteins, Ku70 and Ku86, and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke 2001, 32, 1401-1407.
35. Nishimura, K., Ting, H. J., Harada, Y., Tokizane, T. et al., Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer Res. 2003, 63, 4888-4894.
36. Urbanucci, A.,Waltering, K. K., Suikki, H. E., Helenius, M. A., Visakorpi, T. Androgen regulation of the androgen receptor coregulators. BMC Cancer 2008, 8, 219.
37. Heemers, H. V., Tindall, D. J., Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 2007, 28, 778-808.
38. Koya, R. C., Fujita, H., Shimizu, S., Ohtsu, M. et al., Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 2000, 275, 15343-15349.
39. Thompson, C. C., Ashcroft, F. J., Patel, S., Saraga, G. et al., Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut 2007, 56, 95-106.
40. Renz, M., Betz, B., Niederacher, D., Bender, H. G., Langowski, J., Invasive breast cancer cells exhibit increased mobility of the actin-binding protein CapG. Int. J. Cancer 2008, 122, 1476-1482.
41. Lim, L. H., Pervaiz, S., Annexin 1: the new face of an old molecule. FASEB J. 2007, 21, 968-975.
42. Mueller, P., Massner, J., Jayachandran, R., Combaluzier, B. et al., Regulation of T cell survival through coronin-1- mediated generation of inositol-1,4,5-trisphosphate and calcium mobilization after T cell receptor triggering. Nat. Immunol. 2008, 9, 1207-1208.
43. O'Neill, G. M., Stehn, J., Gunning, P. W., Tropomyosins as interpreters of the signalling environment to regulate the local cytoskeleton. Semin. Cancer Biol. 2008, 18, 35-44.
44. Giretti, M. S., Simoncini, T., Rapid regulatory actions of sex steroids on cell movement through the actin cytoskeleton. Steroids 2008, 73, 895-900.
45. Vassena, L., Proschan, M., Fauci, A. S., Lusso, P., Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+and CD8+T cells from HIV-1-infected individuals. Proc. Natl. Acad. Sci. USA 2007, 104, 2355-2360.
46. Verrills, N. M., Walsh, B. J., Cobon, G. S., Hains, P. G., Kavallaris, M., Proteome analysis of vinca alkaloid response and resistance in acute lymphoblastic leukemia reveals novel cytoskeletal alterations. J. Biol. Chem. 2003, 278, 45082-45093.